Efficacy and Safety Dose Finding Study of Givinostat to Treat Polyarticular Course Juvenile Idiopathic Arthritis
This study has been terminated.
(The primary reason for the decision to discontinue the study is lack of enrolment; this decision is not related to any tolerability concerns with Givinostat)
First Posted: December 16, 2010
Last Update Posted: April 16, 2014
Information provided by (Responsible Party):